Morgan Stanley’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$23.9M Buy
2,571,723
+383,245
+18% +$3.56M ﹤0.01% 2623
2025
Q1
$16M Buy
2,188,478
+365,553
+20% +$2.68M ﹤0.01% 2916
2024
Q4
$15.6M Buy
1,822,925
+238,750
+15% +$2.04M ﹤0.01% 3001
2024
Q3
$13.8M Buy
1,584,175
+421,694
+36% +$3.67M ﹤0.01% 3161
2024
Q2
$7.95M Sell
1,162,481
-210,554
-15% -$1.44M ﹤0.01% 3495
2024
Q1
$12.5M Buy
1,373,035
+726,725
+112% +$6.61M ﹤0.01% 3163
2023
Q4
$2.88M Buy
646,310
+399,885
+162% +$1.78M ﹤0.01% 4735
2023
Q3
$774K Buy
246,425
+13,660
+6% +$42.9K ﹤0.01% 4945
2023
Q2
$1.2M Sell
232,765
-948,938
-80% -$4.9M ﹤0.01% 4728
2023
Q1
$6.23M Buy
1,181,703
+753,831
+176% +$3.97M ﹤0.01% 3591
2022
Q4
$1.2M Buy
427,872
+239,559
+127% +$673K ﹤0.01% 4759
2022
Q3
$782K Sell
188,313
-40,828
-18% -$170K ﹤0.01% 5029
2022
Q2
$920K Buy
229,141
+7,480
+3% +$30K ﹤0.01% 5065
2022
Q1
$1.1M Sell
221,661
-200,711
-48% -$993K ﹤0.01% 4927
2021
Q4
$2.94M Sell
422,372
-226,443
-35% -$1.58M ﹤0.01% 4259
2021
Q3
$6.49M Buy
648,815
+156,948
+32% +$1.57M ﹤0.01% 3404
2021
Q2
$6.97M Buy
491,867
+157,541
+47% +$2.23M ﹤0.01% 3418
2021
Q1
$5.49M Buy
334,326
+72,409
+28% +$1.19M ﹤0.01% 3308
2020
Q4
$5.42M Sell
261,917
-2,710
-1% -$56.1K ﹤0.01% 3175
2020
Q3
$2.01M Buy
264,627
+68,514
+35% +$521K ﹤0.01% 3653
2020
Q2
$1.63M Buy
196,113
+45,981
+31% +$383K ﹤0.01% 3786
2020
Q1
$743K Sell
150,132
-88,589
-37% -$438K ﹤0.01% 4147
2019
Q4
$943K Buy
238,721
+50,335
+27% +$199K ﹤0.01% 4577
2019
Q3
$573K Buy
188,386
+11,922
+7% +$36.3K ﹤0.01% 4618
2019
Q2
$777K Sell
176,464
-54,153
-23% -$238K ﹤0.01% 4366
2019
Q1
$916K Sell
230,617
-93,663
-29% -$372K ﹤0.01% 4171
2018
Q4
$1.29M Buy
324,280
+69,315
+27% +$276K ﹤0.01% 4093
2018
Q3
$1.75M Sell
254,965
-22,831
-8% -$157K ﹤0.01% 4107
2018
Q2
$1.88M Buy
277,796
+5,641
+2% +$38.1K ﹤0.01% 4137
2018
Q1
$1.77M Buy
272,155
+13,230
+5% +$86.1K ﹤0.01% 4116
2017
Q4
$1.15M Sell
258,925
-11,363
-4% -$50.6K ﹤0.01% 4443
2017
Q3
$1.67M Sell
270,288
-128,782
-32% -$796K ﹤0.01% 4041
2017
Q2
$3.7M Sell
399,070
-205,566
-34% -$1.91M ﹤0.01% 3202
2017
Q1
$5.61M Buy
604,636
+275,950
+84% +$2.56M ﹤0.01% 2749
2016
Q4
$2.75M Sell
328,686
-244,623
-43% -$2.05M ﹤0.01% 3626
2016
Q3
$3.94M Buy
573,309
+474,703
+481% +$3.26M ﹤0.01% 2900
2016
Q2
$488K Buy
98,606
+75,784
+332% +$375K ﹤0.01% 4437
2016
Q1
$220K Buy
22,822
+16,572
+265% +$160K ﹤0.01% 4917
2015
Q4
$59K Sell
6,250
-738
-11% -$6.97K ﹤0.01% 5643
2015
Q3
$98K Sell
6,988
-10,616
-60% -$149K ﹤0.01% 5429
2015
Q2
$370K Sell
17,604
-1,038
-6% -$21.8K ﹤0.01% 4914
2015
Q1
$783K Buy
18,642
+3,294
+21% +$138K ﹤0.01% 4318
2014
Q4
$361K Sell
15,348
-50,836
-77% -$1.2M ﹤0.01% 4897
2014
Q3
$992K Buy
+66,184
New +$992K ﹤0.01% 4034